Safety of Intravenous Push Lacosamide Compared ... | 合法藥品大搜索

由 KE Davidson 著作 · 2018 · 被引用 13 次 — Administration of lacosamide via IV push results in similar adverse effect rates to IV piggyback preparations with more efficient time to administration. Read More

由 K McLaughlin 著作 · 2021 · 被引用 1 次 — IVP lacosamide was associated with a similar incidence of cardiovascular, neurological, and infusion site-related adverse events compared ... Read More

由 K McLaughlin 著作 · 2021 · 被引用 1 次 — ... the incidence of adverse events associated with administering lacosamide by intravenous push (IVP) compared with IV piggyback (IVPB). Read More

由 KE Davidson 著作 · 2018 · 被引用 1 次 — Learning Objectives: Intravenous (IV) lacosamide (LCM) use for status epilepticus is increasing in recent years and is recommended for refractory status​ ... Read More

由 JC O'Horo 著作 · 2002 — IV Push Administration of Drugsa. This list is intended to ... Safety and efficiency of intravenous push lacosamide administration. Neurocrit Care ... Read More

VIMPAT injection for intravenous use—indicated as short-term replacement when oral administration is not feasible. The safety of VIMPAT injection in pediatric ... Read More

The overall duration of treatment with intravenous lacosamide is at the physician's discretion; there is experience from clinical studies with twice daily infusions of ... Read More